Overview
Q4 revenue declines to $224.5 mln, impacted by strategic decisions
International cannabis revenue up 71% in Q4
Company reduces total debt repayments of ~$100 mln to date, strengthening balance sheet
Outlook
Tilray expects FY 2026 adjusted EBITDA of $62 mln to $72 mln
Company anticipates growth in cannabis, beverage, and wellness sectors
Tilray plans to enhance global supply chain in 2026
Company sees growth opportunities in Europe and emerging markets
Result Drivers
INTERNATIONAL GROWTH - International cannabis revenue increased by 71% in Q4, driven by strategic market expansions
BEVERAGE STRATEGY - Beverage revenue impacted project 420 and national SKU rationalization across co's recently acquired craft beverage brands
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $224.54 mln |
|
Q4 Adjusted EPS |
| $0.02 |
|
Q4 Net Income |
| -$1.27 bln |
|
Q4 Basic EPS |
| -$1.3 |
|
Analyst Coverage
The one available analyst rating on the shares is "hold"
Wall Street's median 12-month price target for Tilray Brands Inc is C$1.36, about 30.9% above its July 25 closing price of C$0.94
Press Release: ID:nGNX30KSHh